[Adipokines and lipid metabolism in type 2 diabetes].
von Eynatten
M
M
Abteilung Nephrologie, Klinikum rechts der Isar der TU München. maximilian.eynatten@lrz.tum.de
Hamann
A
A
D052242:Adiponectin / Q000502:physiology; D050154:Adiposity / Q000502:physiology; D050197:Atherosclerosis / Q000209:etiology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism*; D050171:Dyslipidemias / Q000209:etiology / Q000378:metabolism; D006801:Humans; D020738:Leptin / Q000502:physiology; D050356:Lipid Metabolism / Q000502:physiology*; D052439:Lipid Metabolism Disorders / Q000150:complications / Q000209:etiology / Q000378:metabolism*; D009765:Obesity / Q000209:etiology / Q000378:metabolism; D036361:Peptide Hormones / Q000502:physiology*; D052243:Resistin / Q000502:physiology
D052242:Adiponectin; D020738:Leptin; D036361:Peptide Hormones; D052243:Resistin